Aclaris Therapeutics Shares Outstanding 2014-2018 | ACRS

Aclaris Therapeutics shares outstanding from 2014 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Aclaris Therapeutics Annual Shares Outstanding (Millions of Shares)
2017	28
2016	21
2015	6
2014	2
2013	1

Aclaris Therapeutics Quarterly Shares Outstanding (Millions of Shares)
Q3 2018	31
Q2 2018	31
Q1 2018	31
Q4 2017	28
Q3 2017	29
Q2 2017	27
Q1 2017	26
Q4 2016	21
Q3 2016	21
Q2 2016	21
Q1 2016	20
Q4 2015	6
Q3 2015	2
Q2 2015	2
Q1 2015	2
Q4 2014	0
Q3 2014	2
Q4 2013	0

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.338B	$0.002B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.

Stock Name	Country	Market Cap	PE Ratio
Shire (SHPG)	Ireland	$52.737B	11.25
Zoetis (ZTS)	United States	$42.323B	28.98
Grifols (GRFS)	Spain	$13.151B	16.05
Tilray (TLRY)	United States	$9.340B	0.00
Jazz Pharmaceuticals (JAZZ)	Ireland	$8.516B	12.22
Neurocrine Biosciences (NBIX)	United States	$7.634B	1683.60
Ionis Pharmaceuticals (IONS)	United States	$7.308B	0.00
Nektar Therapeutics (NKTR)	United States	$6.402B	9.18
Catalent (CTLT)	United States	$5.280B	22.15
Impax Laboratories (AMRX)	United States	$5.180B	0.00
Sage Therapeutics (SAGE)	United States	$4.814B	0.00
United Therapeutics (UTHR)	United States	$4.770B	7.80
Loxo Oncology (LOXO)	United States	$4.133B	0.00
TESARO (TSRO)	United States	$4.071B	0.00
Taro Pharmaceutical Industries (TARO)	Israel	$3.986B	14.76
FibroGen (FGEN)	United States	$3.227B	0.00
USANA Health Sciences (USNA)	United States	$2.879B	24.51
Endo (ENDP)	Ireland	$2.596B	3.98
Xencor (XNCR)	United States	$2.114B	0.00
Heron Therapeutics (HRTX)	United States	$2.071B	0.00
Endocyte (ECYT)	United States	$1.956B	0.00
Pacira Pharmaceuticals (PCRX)	United States	$1.901B	256.83
Ironwood Pharmaceuticals (IRWD)	United States	$1.896B	0.00
Aerie Pharmaceuticals (AERI)	United States	$1.804B	0.00
Zogenix (ZGNX)	United States	$1.786B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$1.740B	0.00
PTC Therapeutics (PTCT)	United States	$1.683B	0.00
Corcept Therapeutics (CORT)	United States	$1.506B	22.10
Theravance Biopharma (TBPH)	Cayman Islands	$1.484B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$1.419B	19.95
Esperion Therapeutics (ESPR)	United States	$1.381B	0.00
Portola Pharmaceuticals (PTLA)	United States	$1.374B	0.00
Spectrum Pharmaceuticals (SPPI)	United States	$1.321B	0.00
Tricida (TCDA)	United States	$1.258B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$1.156B	0.00
TherapeuticsMD (TXMD)	United States	$1.078B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$0.963B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$0.800B	0.00
ImmunoGen (IMGN)	United States	$0.796B	0.00
Radius Health (RDUS)	United States	$0.721B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.634B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.608B	0.00
Forty Seven (FTSV)	United States	$0.572B	0.00
Flexion Therapeutics (FLXN)	United States	$0.566B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$0.522B	0.00
ChemoCentryx (CCXI)	United States	$0.498B	39.40
Akebia Therapeutics (AKBA)	United States	$0.487B	0.00
Siga Technologies (SIGA)	United States	$0.476B	0.00
Dermira (DERM)	United States	$0.459B	0.00
GlycoMimetics (GLYC)	United States	$0.455B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.452B	0.00
Xeris Pharmaceuticals (XERS)	United States	$0.429B	0.00
BioSpecifics Technologies Corp (BSTC)	United States	$0.421B	24.85
Dova Pharmaceuticals (DOVA)	United States	$0.408B	0.00
Odonate Therapeutics (ODT)	United States	$0.402B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.395B	0.00
ArQule (ARQL)	United States	$0.390B	0.00
Tyme Technologies (TYME)	United States	$0.389B	0.00
Translate Bio (TBIO)	United States	$0.385B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.385B	0.00
CASI Pharmaceuticals (CASI)	United States	$0.372B	0.00
La Jolla Pharmaceutical (LJPC)	United States	$0.362B	0.00
OptiNose (OPTN)	United States	$0.333B	0.00
Tapimmune (MRKR)	United States	$0.326B	0.00
Aratana Therapeutics (PETX)	United States	$0.312B	0.00
Minerva Neurosciences (NERV)	United States	$0.309B	0.00
Concert Pharmaceuticals (CNCE)	United States	$0.293B	0.00
Majesco Entertainment (PTE)	United States	$0.293B	0.00
Depomed (ASRT)	United States	$0.273B	10.17
Mast Therapeutics (SVRA)	United States	$0.268B	0.00
IMV INC (IMV)	Canada	$0.266B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.263B	0.00
Affimed (AFMD)	Germany	$0.250B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$0.246B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.242B	0.00
Ocular Therapeutix (OCUL)	United States	$0.239B	0.00
Foamix Pharmaceuticals (FOMX)	Israel	$0.222B	0.00
Marinus Pharmaceuticals (MRNS)	United States	$0.210B	0.00
Lannett Co Inc (LCI)	United States	$0.209B	1.82
AcelRx Pharmaceuticals (ACRX)	United States	$0.208B	0.00
Aquestive Therapeutics (AQST)	United States	$0.206B	0.00
Galectin Therapeutics (GALT)	United States	$0.204B	0.00
TAIWAN LIPOSOME (TLC)	Taiwan	$0.198B	0.00
Opexa Therapeutics (ACER)	United States	$0.195B	0.00
Zafgen (ZFGN)	United States	$0.189B	0.00
Calithera Biosciences (CALA)	United States	$0.187B	0.00
MEI Pharma (MEIP)	United States	$0.184B	0.00
Bellicum Pharmaceuticals (BLCM)	United States	$0.175B	0.00
ContraFect (CFRX)	United States	$0.171B	0.00
Nature's Sunshine Products (NATR)	United States	$0.170B	0.00
Recro Pharma (REPH)	United States	$0.170B	0.00
Neon Therapeutics (NTGN)	United States	$0.162B	0.00
Molecular Templates (MTEM)	United States	$0.160B	0.00
ElectroCore (ECOR)	United States	$0.151B	0.00
Redhill Biopharma (RDHL)	Israel	$0.150B	0.00
Oasmia Pharmaceutical AB (OASM)	Sweden	$0.149B	0.00
MediWound (MDWD)	Israel	$0.146B	0.00
Ardelyx (ARDX)	United States	$0.145B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.135B	0.00
Adamis Pharmaceuticals (ADMP)	United States	$0.134B	0.00
Jounce Therapeutics (JNCE)	United States	$0.129B	0.00
DURECT (DRRX)	United States	$0.127B	0.00
Cardiome Pharma (CORV)	Canada	$0.125B	0.00
Adherex Technologies (FENC)	United States	$0.122B	0.00
ProNAi Therapeutics (SRRA)	Canada	$0.113B	0.00
Champions Oncology (CSBR)	United States	$0.113B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.110B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$0.099B	0.00
Immune Design (IMDZ)	United States	$0.097B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.096B	0.00
Melinta Therapeutics (MLNT)	United States	$0.094B	0.00
Synergy Pharmaceuticals (SGYP)	United States	$0.089B	0.00
Tetraphase Pharmaceuticals (TTPH)	United States	$0.088B	0.00
CTI BioPharma (CTIC)	United States	$0.088B	0.00
Entasis Therapeutics Holdings (ETTX)	United States	$0.078B	0.00
Natural Alternatives (NAII)	United States	$0.077B	7.60
KemPharm (KMPH)	United States	$0.075B	0.00
Infinity Pharmaceuticals (INFI)	United States	$0.073B	0.00
Otonomy (OTIC)	United States	$0.072B	0.00
BioLineRx (BLRX)	Israel	$0.070B	0.00
Nivalis Therapeutics (ALPN)	United States	$0.066B	0.00
Achaogen (AKAO)	United States	$0.064B	0.00
Opiant Pharmaceuticals (OPNT)	United States	$0.061B	0.00
Neos Therapeutics (NEOS)	United States	$0.059B	0.00
Avenue Therapeutics (ATXI)	United States	$0.053B	0.00
Forward Pharma (FWP)	Denmark	$0.052B	0.00
Genocea Biosciences (GNCA)	United States	$0.050B	0.00
Mannatechorporated (MTEX)	United States	$0.047B	0.00
Capnia (SLNO)	United States	$0.038B	0.00
Novan (NOVN)	United States	$0.036B	0.00
Dipexium Pharmaceuticals (PLXP)	United States	$0.036B	0.00
ProPhase Labs (PRPH)	United States	$0.036B	0.00
Heat Biologics (HTBX)	United States	$0.031B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.031B	0.00
Lipocine (LPCN)	United States	$0.030B	0.00
Trillium Therapeutics (TRIL)	Canada	$0.030B	0.00
SCYNEXIS (SCYX)	United States	$0.029B	0.00
Tokai Pharmaceuticals (NVUS)	United States	$0.028B	0.00
PharmAthene (ALT)	United States	$0.028B	0.00
Xenetic Biosciences (XBIO)	United States	$0.024B	0.00
Biomerica (BMRA)	United States	$0.024B	0.00
Jaguar Animal Health (JAGX)	United States	$0.023B	0.00
HANCOCK JAFFE (HJLI)	United States	$0.022B	0.00
Aviragen Therapeutics (VXRT)	United States	$0.021B	0.00
Cyanotech (CYAN)	United States	$0.021B	0.00
Onconova Therapeutics (ONTX)	United States	$0.021B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.019B	0.00
Pain Therapeutics (PTIE)	United States	$0.019B	0.00
Eyegate Pharmaceuticals (EYEG)	United States	$0.018B	0.00
Kitov Pharmaceuticals Holdings (KTOV)	Israel	$0.017B	0.00
Summit Therapeutics (SMMT)	United Kingdom	$0.017B	6.10
CollPlant Holdings Sponsored ADR (CLGN)	Israel	$0.017B	0.00
ESSA Pharma (EPIX)	Canada	$0.016B	0.00
Shineco (TYHT)	China	$0.015B	1.65
Regulus Therapeutics (RGLS)	United States	$0.013B	0.00
DelMar Pharmaceuticals (DMPI)	Canada	$0.012B	0.00
Skyline Medical (AIPT)	United States	$0.011B	0.00
OncoGenex Pharmaceuticals (ACHV)	United States	$0.010B	0.00
Aradigm (ARDM)	United States	$0.008B	0.00
Apricus Biosciences (APRI)	United States	$0.008B	0.00
Ohr Pharmaceuticals (OHRP)	United States	$0.008B	0.00
Midatech Pharma (MTP)	United Kingdom	$0.007B	0.00
RXi Pharmaceuticals (PHIO)	United States	$0.007B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Ritter Pharmaceuticals (RTTR)	United States	$0.005B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.004B	0.00
Bio Blast Pharma (ORPN)	Israel	$0.004B	0.00
Bio-Path Holdings (BPTH)	United States	$0.004B	0.00
Auris Medical Holding AG (EARS)	Switzerland	$0.003B	0.00
Intellipharmaceutics (IPCI)	Canada	$0.003B	0.00
Advanced Accelerator Applications (AAAP)	France	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00